EX-1.1
from 8-K
48 pages
Bone Biologics Corporation Underwriting Agreement 3,777,778 Units Consisting of 3,777,778 Shares of Common Stock, and 3,777,778 Series a Warrants to Purchase 3,777,778 Shares of Common Stock and 3,777,778 Series B Warrants to Purchase 3,777,778 Shares of Common Stock and 3,777,778 Series C Warrants to Purchase 3,777,778 Shares of Common Stock
12/34/56
EX-1.1
from S-1/A
48 pages
Bone Biologics Corporation Underwriting Agreement 1,923,077 Units Consisting of 1,923,077 Shares of Common Stock, and 1,923,077 Series a Warrants to Purchase 1,923,077 Shares of Common Stock and 1,923,077 Series B Warrants to Purchase 1,923,077 Shares of Common Stock and 1,923,077 Series C Warrants to Purchase 1,923,077 Shares of Common Stock
12/34/56
EX-1.1
from S-1/A
48 pages
Bone Biologics Corporation Underwriting Agreement 1,923,077 Units Consisting of 1,923,077 Shares of Common Stock, and 1,923,077 Series a Warrants to Purchase 1,923,077 Shares of Common Stock and 1,923,077 Series B Warrants to Purchase 1,923,077 Shares of Common Stock and 1,923,077 Series C Warrants to Purchase 1,923,077 Shares of Common Stock
12/34/56
EX-1.1
from 8-K
49 pages
Bone Biologics Corporation Underwriting Agreement 1,510,455 Units Consisting of 1,510,455 Shares of Common Stock and 1,510,455 Warrants to Purchase 1,510,455 Shares of Common Stock
12/34/56